PHIO PHARMACEUTICALS CORP. Shareholders' Equity
PHIO PHARMACEUTICALS CORP. (PHIO) had Shareholders' Equity of $12.60 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $12.60M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $16.46M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $20.15M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.84M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $12.60M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $16.46M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $20.15M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $9.84M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $10.10M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $12.17M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $4.72M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $4.95M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $3.77M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $5.60M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $7.73M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $7.21M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $9.90M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $7.31M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $10.84M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $13.53M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $17.00M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $19.45M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $21.93M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $25.25M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $28.84M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $31.40M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $13.02M 10-K · filed 2023-03-22 | |
| 2020-09-30 | $15.45M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $17.73M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $11.98M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $5.75M 10-K · filed 2022-03-22 | |
| 2019-09-30 | $7.61M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $9.71M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $11.66M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $13.58M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $1.75M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $3.27M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $567.00K 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $1.83M 10-K · filed 2020-03-26 | |
| 2017-09-30 | $3.43M 10-Q/A · filed 2018-03-26 | |
| 2017-06-30 | $5.94M 10-Q/A · filed 2018-03-26 | |
| 2017-03-31 | $8.25M 10-Q/A · filed 2018-03-26 | |
| 2016-12-31 | $10.86M 10-K · filed 2019-03-27 | |
| 2016-09-30 | $3.04M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $4.97M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $6.95M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $8.89M 10-K · filed 2018-03-26 | |
| 2015-09-30 | $11.03M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $13.13M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $2.53M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $2.75M 10-K · filed 2017-03-30 | |
| 2014-09-30 | $4.72M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $6.56M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $6.22M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $4.94M 10-K · filed 2016-03-30 | |
| 2013-09-30 | $7.05M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $6.71M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $8.12M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$5.84M 10-K · filed 2015-03-30 | |
| 2012-09-30 | -$4.27M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$2.78M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$1.78M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | -$587.00K 10-K · filed 2014-03-28 | |
| 2010-12-31 | $2.43M 10-K · filed 2014-03-28 | |
| 2009-12-31 | $741.00K 10-K · filed 2014-03-28 | |
| 2008-12-31 | $8.97M 10-K · filed 2014-03-28 | |
| 2007-12-31 | $10.82M 10-K · filed 2014-03-28 | |
| 2006-12-31 | $2.00K 10-K · filed 2014-03-28 | -$268.00K 10-Q · filed 2012-08-14 |
| 2006-04-03 | $0.00 10-Q · filed 2013-08-14 | |
| 2005-12-31 | -$450.00K 10-Q · filed 2013-05-15 | |
| 2004-12-31 | -$968.00K 10-Q · filed 2013-05-15 | |
| 2003-12-31 | -$89.00K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |